Literature DB >> 3677981

Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy.

M T Gadia1, N Natori, L B Ramos, D R Ayyar, J S Skyler, J M Sosenko.   

Abstract

We have examined associations between height and quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy in adult diabetic patients. Vibratory sensitivity was strongly related to height when measurements were made with either the vibration sensitivity tester (P = .02) or the biothesiometer (P less than .01); however, there was no relation between thermal sensitivity (as measured with the thermal sensitivity tester) and height. The peroneal and posterior tibial motor nerve-conduction velocities were inversely related to height (P less than .05 for both). When age and diabetes duration were included as variables in multiple regression analyses, the associations with height became stronger. Clinical indices of peripheral neuropathy were also related to height in these analyses. Glycosylated hemoglobin was significantly related to thermal sensitivity and the peroneal and posterior tibial motor nerve-conduction velocities but not to vibratory sensitivity. These data indicate that height has a marked influence on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy.

Entities:  

Mesh:

Year:  1987        PMID: 3677981     DOI: 10.2337/diacare.10.5.613

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

Review 1.  Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Authors:  Anna Grisold; Brian C Callaghan; Eva L Feldman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

2.  Peripheral insensate neuropathy-is height a risk factor?

Authors:  G S Sharath Kote; Ajay N Bhat; Thajuddeen K; Mohammed H Ismail; Abhishek Gupta
Journal:  J Clin Diagn Res       Date:  2012-12-24

3.  Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?

Authors:  Chin-Hsiao Tseng
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

4.  Measurement of perception threshold to an electric stimulus using a phase-sensitive technique in normal and diabetic subjects.

Authors:  S Prună; C Ionescu-Tîrgovişte; E Popa; I Mincu
Journal:  Med Biol Eng Comput       Date:  1989-03       Impact factor: 2.602

5.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

6.  Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™).

Authors:  Kazuhiro Hirayasu; Hideyuki Sasaki; Shohei Kishimoto; Seigo Kurisu; Koji Noda; Kenichi Ogawa; Hiroto Tanaka; Yumiko Sakakibara; Shohei Matsuno; Hiroto Furuta; Mikio Arita; Keigo Naka; Kishio Nanjo
Journal:  J Diabetes Investig       Date:  2018-03-06       Impact factor: 4.232

7.  Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Authors:  Jackie Elliott; Solomon Tesfaye; Nish Chaturvedi; Rajiv A Gandhi; Lynda K Stevens; Celia Emery; John H Fuller
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

8.  Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.

Authors:  Anne-Caroline Jeannin; Joe-Elie Salem; Ziad Massy; Carole Elodie Aubert; Cees Vemeer; Chloé Amouyal; Franck Phan; Marine Halbron; Christian Funck-Brentano; Agnès Hartemann; Olivier Bourron
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.